Want to join the conversation?
During 1Q16, $MYL's largest contributing segment Generics third party net sales increased 17% to $1.93Bil compared to the prior year period, helped by higher sales in North America, Europe and Rest of World. Specialty segment third party net sales rose 17% during 1Q16 helped by higher net sales of the EpiPen Auto-Injector due to higher volumes.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.